Lebrikizumab

Product Name: Lebrikizumab
CAS No.: 953400-68-5
Chemical Name: Lebrikizumab
Synonyms: Lebrikizumab;Research Grade Lebrikizumab(DHE07702)
CBNumber: CB88080808
Formula Weight: 0
MOL File: Mol file

More

Less

Lebrikizumab Property

form: Liquid
color: Colorless to light yellow

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

Lebrikizumab Chemical Properties,Usage,Production

Uses

Lebrikizumab has been used in trials studying the treatment of Asthma, Allergic Asthma, Atopic Dermatitis, Idiopathic Pulmonary Fibrosis, and COPD, Chronic Obstructive Pulmonary Disease.

Lebrikizumab Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Lebrikizumab Suppliers

China 8 Global 8

ShangHai Biochempartner Co.,Ltd

Tel: 177-54423994 17754423994
Fax: QQ:2853530913
Email: 2853530910@QQ.com
Country: China
ProdList: 8011
Advantage: 62

Guangzhou Hongyuan Chemical Co.,Ltd

Tel: 15817493340
Email: 981810490@qq.com
Country: China
ProdList: 1566
Advantage: 58

Wuhan Chemstan Biotechnology Co., Ltd.

Tel: 027-65317797 15926423062
Fax: QQ：422450190
Email: 422450190@qq.com
Country: China
ProdList: 10424
Advantage: 58

Biolab Reagents

Tel: 027-65279366 18108604862
Email: products@biolabreagent.com
Country: China
ProdList: 9818
Advantage: 58

Wuhan Jingkangen Biomedical Technology Co., Ltd

Tel: 13720134139 13720134139
Email: orders@jknbiochem.com
Country: China
ProdList: 5821
Advantage: 58

Shanghai Yifei Biotechnology Co. , Ltd.

Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Country: China
ProdList: 11974
Advantage: 58

Changsha Fuzhen Biotechnology Co.，LTD

Tel: 13823398779 18670069958
Email: 3062105966@qq.com
Country: China
ProdList: 3262
Advantage: 58

Wanxin Biotechnology (Jiaxing) Co., LTD

Tel: 0573-83568680 18057391398
Email: 3956524501@qq.com
Country: China
ProdList: 1442
Advantage: 58

953400-68-5, LebrikizumabRelated Search:

Etokima Tralokinumab Ustekinumab Simtuzumab Vedolizumab TocilizuMab dupilumab mepolizumab Clazakizumab Ieramilimab

Lebrikizumab

Research Grade Lebrikizumab(DHE07702)

953400-68-5